Qube Research & Technologies LTD Alpha Tau Medical Ltd. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 24 shares of DRTS stock, worth $57. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 24
-0.0%
Holding current value
$57
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.42MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY280KShares$673,1010.07% of portfolio
-
Hoyle Cohen, LLC269KShares$645,8110.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$553,6890.0% of portfolio
-
Corbin Capital Partners, L.P. New York, NY97.2KShares$233,2720.69% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$159,1820.01% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $166M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...